Clovis Oncology Announces 2013 Operating Results and Expands CO-1686 Development Program

[Business Wire] – Clovis Oncology, Inc. reported financial results for its quarter and year ended December 31, 2013, and provided an update on the expected milestones for its clinical more

View todays social media effects on CLVS

View the latest stocks trending across Twitter. Click to view dashboard

See who Clovis is hiring next, click here to view